EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Pediatric Blood and Cancer

Description
official journal of the International Society of Paediatric Oncology, the American Society of Pediatric Hematology, Oncology, the Histiocyte Society

 

Status
active
Indexing
Biological Abstracts® (Thomson ISI); BIOSIS Previews® (Thomson ISI); CAB Abstracts® (CABI); CINAHL: Cumulative Index to Nursing & Allied Health Literature (EBSCO); Current Awareness in Biological Sciences (Elsevier); Current Contents®/Clinical Medicine (Thomson ISI); Current Opinion in Pediatrics (Lippincott Williams & Wilkins); EMBASE/Excerpta Medica (Elsevier); Index Medicus/MEDLINE/PubMed (NLM):
Journal Citation Reports/Science Edition (Thomson ISI); Leeds Medical Information (University of Leeds); PASCAL Database (INIST/CNRS); Science Citation Index Expanded™ (Thomson ISI); Science Citation Index® (Thomson ISI); SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica); VINITI (All-Russian Institute of Science & Technological Information); Web of Science® (Thomson ISI)
Predecessor
Subject

Source type
Journal
Publisher
ISBN ISSN
1545-5017
First volume
42
Last volume
55+
Publish city
Hoboken
Homepage
Description
Pediatric Blood & Cancer will publish in print and online, the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood, including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.











Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )